Barclays - November 16 

Canaccord Genuity - November 19 

Piper Jaffray - December 1

SOUTH JORDAN, Utah, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at three investor conferences in the next few weeks.

On Monday, November 16, Merit's Chairman and Chief Executive Officer Fred P. Lampropoulos and Chief Financial Officer Bernard Birkett will participate in one-on-one meetings at the Barclays MedTech SMID Cap Day Conference in Barclays' New York City office. 

On Thursday, November 19, at 4:30 p.m. ET, Lampropoulos will present at Canaccord Genuity's Medical Technologies & Diagnostics Forum at the Westin Grand Central in New York City.  He and Birkett will participate in one-on-one meetings throughout the day.

On Tuesday, December 1, at 12:00 noon ET, Lampropoulos will participate in a panel discussion entitled "Insights from MedTech Founder CEOs" at the 27 th Annual Piper Jaffray Healthcare Conference at The Lotte New York Palace.  He and Birkett will also participate in one-on-one meetings throughout the day.


Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy.  Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 200 individuals.  Merit employs approximately 3,700 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; and Rockland, Massachusetts.

Contact:  Anne-Marie Wright, Vice President, Corporate CommunicationsPhone:  (801) 208-4167  e-mail:  Fax: (801) 253-1688

Primary Logo